Literature DB >> 7267039

Long-term evaluation of patients with Best's vitelliform dystrophy.

C W Mohler, S L Fine.   

Abstract

We examined 91 patients with Best's dystrophy and followed 54 affected individuals for five years. Most eyes with normal maculas, minimal pigment epithelial changes, atrophic maculae, or fibrous macular scars did not change stage. Eyes with vitelliform or pseudohypopyon lesions progressed to later atrophic macular stages. Visual acuity decreased after age 40 and was worse for patients with atrophic maculas and fibrous scars. Nineteen percent of patients with atrophic maculas or fibrous scars who were followed for 8 to 10 years were the only patients to lose vision.

Entities:  

Mesh:

Year:  1981        PMID: 7267039     DOI: 10.1016/s0161-6420(81)34965-3

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  35 in total

1.  Multimodal fundus imaging in Best vitelliform macular dystrophy.

Authors:  Daniela C Ferrara; Rogério A Costa; Stephen Tsang; Daniela Calucci; Rodrigo Jorge; K Bailey Freund
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-04-23       Impact factor: 3.117

Review 2.  Bestrophins and retinopathies.

Authors:  Qinghuan Xiao; H Criss Hartzell; Kuai Yu
Journal:  Pflugers Arch       Date:  2010-03-28       Impact factor: 3.657

3.  Functional assessment of the fundus autofluorescence pattern in Best vitelliform macular dystrophy.

Authors:  Maurizio Battaglia Parodi; Pierluigi Iacono; Claudia Del Turco; Giacinto Triolo; Francesco Bandello
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-10-21       Impact factor: 3.117

Review 4.  Bestrophin 1 and retinal disease.

Authors:  Adiv A Johnson; Karina E Guziewicz; C Justin Lee; Ravi C Kalathur; Jose S Pulido; Lihua Y Marmorstein; Alan D Marmorstein
Journal:  Prog Retin Eye Res       Date:  2017-01-30       Impact factor: 21.198

Review 5.  Electrophysiology and inherited retinal disorders.

Authors:  G A Fishman
Journal:  Doc Ophthalmol       Date:  1985-08-30       Impact factor: 2.379

Review 6.  [Best's disease. Overview of pathology and its causes].

Authors:  B Lorenz; M N Preising
Journal:  Ophthalmologe       Date:  2005-02       Impact factor: 1.059

7.  New VMD2 gene mutations identified in patients affected by Best vitelliform macular dystrophy.

Authors:  D Marchant; K Yu; K Bigot; O Roche; A Germain; D Bonneau; V Drouin-Garraud; D F Schorderet; F Munier; D Schmidt; P Le Neindre; C Marsac; M Menasche; J L Dufier; R Fischmeister; C Hartzell; M Abitbol
Journal:  J Med Genet       Date:  2007-02-07       Impact factor: 6.318

8.  Pattern dystrophy of the retinal pigment epithelium with vitelliform macular lesion: evolution in ten years.

Authors:  F Cardillo Piccolino; M Zingirian
Journal:  Int Ophthalmol       Date:  1988-02       Impact factor: 2.031

9.  Macular translocation in a patient with adult-onset foveomacular vitelliform dystrophy with light- and electron-microscopic observations on the surgically removed subfoveal tissue.

Authors:  Claus Eckardt; Ute Eckardt; Stephanie Groos; Liliana Luciano; Enrico Reale
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-05-11       Impact factor: 3.117

10.  Functional and clinical data of Best vitelliform macular dystrophy patients with mutations in the BEST1 gene.

Authors:  Giuseppe Querques; Jennyfer Zerbib; Rossana Santacroce; Maurizio Margaglione; Nathalie Delphin; Jean-Michel Rozet; Josseline Kaplan; Domenico Martinelli; Nicola Delle Noci; Gisèle Soubrane; Eric H Souied
Journal:  Mol Vis       Date:  2009-12-31       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.